[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Boston Scientific Corp (BSX)

Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 78,291,696
  • Shares Outstanding, K 1,486,175
  • Annual Sales, $ 20,074 M
  • Annual Income, $ 2,898 M
  • EBIT $ 4,699 M
  • EBITDA $ 6,113 M
  • 60-Month Beta 0.62
  • Price/Sales 3.96
  • Price/Cash Flow 13.27
  • Price/Book 3.05

Options Overview Details

View History
  • Implied Volatility 37.39% (-0.37%)
  • Historical Volatility 46.43%
  • IV Percentile 84%
  • IV Rank 61.79%
  • IV High 49.76% on 03/27/26
  • IV Low 17.38% on 07/29/25
  • Expected Move (DTE 3) 1.70 (3.04%)
  • Put/Call Vol Ratio 0.60
  • Today's Volume 28,393
  • Volume Avg (30-Day) 26,927
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 383,567
  • Open Int (30-Day) 329,455
  • Expected Range 54.22 to 57.62

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 31 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.84
  • Number of Estimates 8
  • High Estimate $0.84
  • Low Estimate $0.83
  • Prior Year $0.75
  • Growth Rate Est. (year over year) +12.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.52 +6.47%
on 05/15/26
66.88 -16.39%
on 04/23/26
-8.31 (-12.94%)
since 04/17/26
3-Month
52.52 +6.47%
on 05/15/26
76.87 -27.25%
on 02/27/26
-20.36 (-26.69%)
since 02/18/26
52-Week
52.52 +6.47%
on 05/15/26
109.50 -48.93%
on 09/09/25
-50.12 (-47.27%)
since 05/16/25

Most Recent Stories

More News
Oil prices keep swinging, and so do stocks worldwide

Oil prices and stock markets worldwide swung with uncertainty about what will happen with the Iran war

NVDA : 222.32 (-1.33%)
D : 67.56 (+9.44%)
$SPX : 7,403.05 (-0.07%)
BSX : 55.92 (+6.15%)
$DOWI : 49,686.12 (+0.32%)
BRK : 193.01 (-0.41%)
REGN : 629.68 (-9.82%)
$IUXX : 28,994.37 (-0.45%)
NEE : 89.04 (-4.63%)
Stocks Settle Mixed as Iran War Remains Unresolved

The S&P 500 Index ($SPX ) (SPY ) on Monday closed down -0.07%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.45%. June E-mini...

MSTR : 166.63 (-6.08%)
AMAT : 413.57 (-5.28%)
AVGO : 420.71 (-1.05%)
SNDK : 1,333.01 (-5.30%)
D : 67.56 (+9.44%)
HIMS : 22.29 (-11.02%)
MBLY : 9.34 (-6.79%)
GLXY : 27.87 (-5.88%)
$IUXX : 28,994.37 (-0.45%)
COIN : 189.44 (-3.07%)
ASML : 1,472.39 (-1.96%)
ZNM26 : 109-050 (+0.13%)
Boston Scientific enters into $2 billion accelerated share repurchase agreement

MARLBOROUGH, Mass. , May 18, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into an accelerated share repurchase (ASR) agreement with JPMorgan...

BSX : 55.92 (+6.15%)
Boston Scientific announces strategic investment in MiRus LLC

Agreement includes exclusive option to acquire novel, balloon-expandable transcatheter aortic valve made with proprietary rhenium alloy

BSX : 55.92 (+6.15%)
2 Large-Cap Stocks to Consider Right Now and 1 We Turn Down

2 Large-Cap Stocks to Consider Right Now and 1 We Turn Down

BSX : 55.92 (+6.15%)
HPE : 33.00 (-0.30%)
BMY : 57.31 (+0.54%)
3 Growth Stocks to Add to Your Roster

3 Growth Stocks to Add to Your Roster

GOOGL : 396.94 (+0.04%)
BSX : 55.92 (+6.15%)
BOW : 28.68 (+1.52%)
Penumbra, Inc. Reports First Quarter 2026 Financial Results

ALAMEDA, Calif. , May 6, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the first quarter ended March 31, 2026.

BSX : 55.92 (+6.15%)
PEN : 326.54 (+1.31%)
BSX FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Boston Scientific To Contact Him Directly To Discuss...

BSX : 55.92 (+6.15%)
Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results

MARLBOROUGH, Mass. , May 4, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Bernstein's 42 nd Annual Strategic Decisions Conference on Wednesday, May 27, 2026....

BSX : 55.92 (+6.15%)
Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa. , May 1, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action...

BSX : 55.92 (+6.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and...

See More

Key Turning Points

3rd Resistance Point 59.89
2nd Resistance Point 58.11
1st Resistance Point 57.01
Last Price 55.92
1st Support Level 54.14
2nd Support Level 52.36
3rd Support Level 51.26

See More

52-Week High 109.50
Fibonacci 61.8% 87.73
Fibonacci 50% 81.01
Fibonacci 38.2% 74.29
Last Price 55.92
52-Week Low 52.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.